DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Gallium Dotatoc Ga 68 is a drug marketed by Uihc Pet Imaging and is included in one NDA.
The generic ingredient in GALLIUM DOTATOC GA 68 is gallium dotatoc ga-68 . There are sixteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the gallium dotatoc ga-68 profile page.
Generic Entry Opportunity Date for GALLIUM DOTATOC GA 68
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for GALLIUM DOTATOC GA 68
Identify potential brand extensions & 505(b)(2) entrants
|National Institutes of Health (NIH)||N/A|
|National Cancer Institute (NCI)||N/A|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Uihc Pet Imaging||GALLIUM DOTATOC GA 68||gallium dotatoc ga-68||SOLUTION;INTRAVENOUS||210828-001||Aug 21, 2019||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|